SLAMF7 and Miyoshi myopathy: To confirm the feasibility of CS1-CAR T cells for the treatment of MM, researchers examined the effect of CS1-CAR T cells on various MM cells, and the data showed that CS1-CAR T cells had antigen-dependent killing effects.